SGEN Stock: Merck’s Rumored Takeover Hits A Snag On Price

Merck‘s (MRK) rumored takeover of cancer-focused biotech Seagen (SGEN) has stalled on price, according to a report Friday that sent SGEN stock tumbling. X So far, the companies have failed to ag...

Merck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%

Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since Febr...

WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

Topline The World Health Organization has recommended Merck’s molnupiravir to treat high-risk Covid patients, the agency announced Thursday, the first oral antiviral it has endorsed though availabilit...

Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study

Topline Merck and Ridgeback Biotherapeutics’ Covid-19 antiviral pill molnupiravir reduced the risk of hospitalization by over 65% in a clinical trial conducted by their Indian partner Hetero, the comp...